Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Medpace Holdings Inc: Is Infosys Ltd. worth buying?
Item: Medpace Holdings Inc
Rating: 1.95309725
Author: Trendlyne DVM scores

Expensive Performer

about

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

538.23 2.73 (0.51%)

75.49% Gain from 52W Low

177.5K

XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Medpace Holdings Inc is on 22 Jul 2026 for the purpose of Medpace Holdings Inc Second Quarter Earnings Results for 2026 See details

Medium Financial Strength

38.9 / 100

Expensive Valuation

25.5 / 100

Technically Neutral

53.0 / 100

Expensive Performer These stocks have medium quality and momentum.Their expensive valuations suggest caution View Similar Embed DVM

451

1Yr Price target downside is -16%

12 analysts

Medpace Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Medpace Holdings Inc Live Stock Price Today, Share Analysis and Chart

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

75.49% Gain from 52W Low

SWOT Analysis

Medpace Holdings Inc Live Price Chart

Medpace Holdings Inc Live Price Chart